Tag: Pharma

Within the healthcare industry, the medical devices segment is expected to be the biggest beneficiary, with additional revenues of USD 2 billion.................

The Health Dialogue 2019, curated by the Organisation of Pharmaceutical Producers of India witnessed the launch of #RefreshingResearch, a nation-wide digital campaign across pharma colleges. Research papers released at the event included.............

Sun Pharma and China Medical System Holdings have entered into licensing agreement for generic products in Mainland China..............

The entire gamut of biologic drugs, of which biosimilars are crucial, is set to become an integral part of the future healthcare landscape, writes Shveta Garg while taking us through the current status of the market and future perspectives...............

Experts suggest that it is a matter of time when products in genome sequencing will become affordable and the Indian genome sequencing market will progress towards maturity.................

Cipla USA to hold worldwide rights (excluding Greater China) of ZEMDRI™ (IV Plazomicin), an IV aminoglycoside with once-daily dosing for cUTI in adults, with proven activity against certain drug-resistant bacteria.......................

The NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs. 5.56 crore has been recovered and demand notices amounting to Rs. 89.31 crore are under litigation....................

The company has launched Enzyme Replacement Therapy bouquet for Lysosomal Storage Disorders (LSD), Idursulfase for Hunter Syndrome, Velaglucerase Alpha for Gaucher Disease and Agalsidase Alfa for Fabry Disease..........................

STARLIMS QM 12.0 is designed for the global manufacturing and R&D sectors including pharmaceuticals/biotech, chemicals and petrochemicals, oil and gas, food and beverage, contract services, consumer products and general manufacturing................

The enhanced capability opens the Michigan site up to a new base of customers, including the antibody drug conjugate (ADC) market.............................